Trifluoroacetic acid → HCID 67389228, compound
Reaction equation
C(OC([N:8]1[CH2:13][CH2:12][N:11]([C:14]([C:16]2([NH:19][C:20]([C:22]3[N:26]4[C@@:27]([CH2:40][C:41]5[CH:46]=[CH:45][C:44]([C:47]#[N:48])=[CH:43][CH:42]=5)([CH3:39])[C:28](=[O:38])[N:29]([C:30]5[CH:35]=[C:34]([Cl:36])[CH:33]=[C:32]([Cl:37])[CH:31]=5)[C:25]4=[N:24][CH:23]=3)=[O:21])[CH2:18][CH2:17]2)=[O:15])[CH:10]([C:49]([O:51]C(C)(C)C)=[O:50])[CH2:9]1)=O)(C)(C)C.[C:56]([OH:62])([C:58]([F:61])([F:60])[F:59])=[O:57]>C(Cl)Cl>[F:59][C:58]([F:61])([F:60])[C:56]([OH:62])=[O:57].[C:47]([C:44]1[CH:45]=[CH:46][C:41]([CH2:40][C@@:27]2([CH3:39])[N:26]3[C:22]([C:20]([NH:19][C:16]4([C:14]([N:11]5[CH2:12][CH2:13][NH:8][CH2:9][CH:10]5[C:49]([OH:51])=[O:50])=[O:15])[CH2:17][CH2:18]4)=[O:21])=[CH:23][N:24]=[C:25]3[N:29]([C:30]3[CH:31]=[C:32]([Cl:37])[CH:33]=[C:34]([Cl:36])[CH:35]=3)[C:28]2=[O:38])=[CH:42][CH:43]=1)#[N:48]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
4-(1-{[(R)-5-(4-Cyano-benzyl)-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carbonyl]-amino}-cyclopropanecarbonyl)-piperazine-1,3-dicarboxylic acid di-tert-butyl ester (256 mg, 0.32 mmol) was dissolved in CH2Cl2 (2 mL) and TFA (2 mL) was added dropwise. After 16 h, the reaction was concentrated in vacuo. The crude orange oil was dissolved in DMSO (1.5 mL), purified via reverse phase HPLC to afford 64 mg of 1-(1-{[(R)-5-(4-cyano-benzyl)-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-carbonyl]-amino}-cyclo-propanecarbonyl)-piperazine-2-carboxylic acid trifluoroacetic acid salt as a white solid.
Workup
- concentrationthe reaction was concentrated in vacuo
- dissolutionThe crude orange oil was dissolved in DMSO (1.5 mL)
- custompurified via reverse phase HPLC
Sources & evidence
- ORD record
- ord-797ab4a02a044403ba2f14192733b769
- Source dataset
- uspto-grants-2013_10
- Patent number
- US08552205B2
Reaction notes
Loading…